o2h Discovery is a full-service Contract Research Organisation with R&D sites in Ahmedabad, India, and Cambridge, UK. With over 800 scientists and support staff, we’ve spent two decades partnering with biotech and pharmaceutical companies to advance discovery programmes across the globe.
Our ONLINE one-day Certified COSHH for Laboratories and Research course is suitable for employees of all levels working in the lab environment.
We have designed this course to cover the fundamental requirements of the Control of Substances Hazardous to Health Regulations, providing you with the tools and confidence to identify hazards, assess risk, measure impacts and implement controls in line with best practice. Not only do we give you the basics, but we also delve in to managing high risk substances and scenarios efficiently.
Our one-day Online Certified COSHH for Laboratories and Research course is suitable for employees of all levels working in the lab environment.
We have designed this course to cover the fundamental requirements of the Control of Substances Hazardous to Health Regulations, providing you with the tools and confidence to identify hazards, assess risk, measure impacts and implement controls in line with best practice. Not only do we give you the basics, but we also delve in to managing high risk substances and scenarios efficiently.
LONDON, UK - December 10, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, today announced a further strengthening of its senior leadership with Ian Coyne joining the Managing Partners group.
January has you setting ambitious targets again - but are they the right targets?
Whether you're leading a team or building a business, most high-performers are running on inherited success frameworks - the same achievement patterns that worked at school or in more junior roles. But the systems that got you here won't get you where you're trying to go.
Showcasing Cambridge & London life science, biotech, deeptech & techbio ventures, offering investors early insight, and emerging innovation.
For many in the global life sciences industry, JPM Week at the start of the year in San Francisco is seen a sone of those pivotal weeks that sets the tone for the forthcoming months as investors, companies, advisors and policymakers all converge at scale around a plethora of events and activities.
One Nucleus will be delighted to be supporting our members in their endeavours to connect with their peers and instigate the deal flow that will shape their 2026. Below is a summary of the opportunities for our members:
RESI JPM
The UK has the potential to unlock £8[1] in socio-economic returns for every £1 spent on preventive healthcare, according to a new health report by Deloitte.
Building and nurturing relationships is an essential part of successful business partnerships. BIO-Europe Spring brings together over 3,700 leading executives from around the world, hosting more than 20,000 partnering meetings between biotech companies, startups and academia with pharma companies and forward-thinking investors.
Through partnership with One Nucleus partners, EBD Group, One Nucleus looks forward to supporting our members again this year at BIO-Europe Spring 2025.
Cutting-edge product for stem cell research and human embryo modelling
Amsbio reports that its iMatrix-511 recombinant laminin product has been cited in a recent paper** from researchers at the Stanford University School of Medicine, Stanford, CA, USA as a pivotal tool for stem cell culture and blastoid formation.